115 related articles for article (PubMed ID: 32533133)
1. The limited use of US residual newborn screening dried bloodspots for health disparity research.
Riches NO; Johnson EP; Frost CJ; Goldenberg AJ; Rothwell E
Genet Med; 2020 Oct; 22(10):1723-1726. PubMed ID: 32533133
[TBL] [Abstract][Full Text] [Related]
2. Secondary research uses of residual newborn screening dried bloodspots: a scoping review.
Rothwell E; Johnson E; Riches N; Botkin JR
Genet Med; 2019 Jul; 21(7):1469-1475. PubMed ID: 30531811
[TBL] [Abstract][Full Text] [Related]
3. What parents want to know about the storage and use of residual newborn bloodspots.
Botkin JR; Rothwell E; Anderson RA; Goldenberg A; Kuppermann M; Dolan SM; Rose NC; Stark L
Am J Med Genet A; 2014 Nov; 164A(11):2739-44. PubMed ID: 25131714
[TBL] [Abstract][Full Text] [Related]
4. Gamma-Hydroxybutyrate content in dried bloodspots facilitates newborn detection of succinic semialdehyde dehydrogenase deficiency.
Brown M; Ashcraft P; Arning E; Bottiglieri T; Roullet JB; Gibson KM
Mol Genet Metab; 2019; 128(1-2):109-112. PubMed ID: 31345667
[TBL] [Abstract][Full Text] [Related]
5. Retention and research use of residual newborn screening bloodspots.
Botkin JR; Goldenberg AJ; Rothwell E; Anderson RA; Lewis MH
Pediatrics; 2013 Jan; 131(1):120-7. PubMed ID: 23209103
[TBL] [Abstract][Full Text] [Related]
6. Parental Consent for the Use of Residual Newborn Screening Bloodspots: Respecting Individual Liberty vs Ensuring Public Health.
Bayefsky MJ; Saylor KW; Berkman BE
JAMA; 2015 Jul; 314(1):21-2. PubMed ID: 26053685
[No Abstract] [Full Text] [Related]
7. Factors associated with maternal consent for use of residual newborn bloodspots in the National Birth Defects Prevention Study.
Wong EC; Fisher SC; Feldkamp ML; Romitti PA; Nestoridi E; Desrosiers TA;
Birth Defects Res; 2022 Apr; 114(7):238-248. PubMed ID: 35194969
[TBL] [Abstract][Full Text] [Related]
8. Neonatal Lead (Pb) Exposure and DNA Methylation Profiles in Dried Bloodspots.
Montrose L; Goodrich JM; Morishita M; Kochmanski J; Klaver Z; Cavalcante R; Lumeng JC; Peterson KE; Dolinoy DC
Int J Environ Res Public Health; 2020 Sep; 17(18):. PubMed ID: 32957503
[TBL] [Abstract][Full Text] [Related]
9. Public attitudes regarding the use of residual newborn screening specimens for research.
Botkin JR; Rothwell E; Anderson R; Stark L; Goldenberg A; Lewis M; Burbank M; Wong B
Pediatrics; 2012 Feb; 129(2):231-8. PubMed ID: 22250018
[TBL] [Abstract][Full Text] [Related]
10. Maternal attitudes and knowledge about newborn screening.
Newcomb P; True B; Walsh J; Dyson M; Lockwood S; Douglas B
MCN Am J Matern Child Nurs; 2013; 38(5):289-94; quiz 295-6. PubMed ID: 23799342
[TBL] [Abstract][Full Text] [Related]
11. A comparative analysis of the governance and use of residual dried blood spots from state newborn screening programs and neonatal biobanks.
Preslan ED; Mathews DJ
J Empir Res Hum Res Ethics; 2013 Jul; 8(3):22-33. PubMed ID: 23933773
[TBL] [Abstract][Full Text] [Related]
12. State laws regarding the retention and use of residual newborn screening blood samples.
Lewis MH; Goldenberg A; Anderson R; Rothwell E; Botkin J
Pediatrics; 2011 Apr; 127(4):703-12. PubMed ID: 21444595
[TBL] [Abstract][Full Text] [Related]
13. Attitudes of parents of children with serious health conditions regarding residual bloodspot use.
Nagaraj CB; Rothwell E; Hart K; Latimer S; Schiffman JD; Botkin JR
Public Health Genomics; 2014; 17(3):141-8. PubMed ID: 24713606
[TBL] [Abstract][Full Text] [Related]
14. Evolution of an influenza pandemic in 13 countries from 5 continents monitored by protein microarray from neonatal screening bloodspots.
de Bruin E; Loeber JG; Meijer A; Castillo GM; Cepeda ML; Torres-Sepúlveda MR; Borrajo GJ; Caggana M; Giguere Y; Meyer M; Fukushi M; Devi AR; Khneisser I; Vilarinho L; von Döbeln U; Torresani T; Mackenzie J; Zutt I; Schipper M; Elvers LH; Koopmans MP
J Clin Virol; 2014 Sep; 61(1):74-80. PubMed ID: 25017954
[TBL] [Abstract][Full Text] [Related]
15. Using Newborn Screening Bloodspots for Research: Public Preferences for Policy Options.
Hayeems RZ; Miller FA; Barg CJ; Bombard Y; Cressman C; Painter-Main M; Wilson B; Little J; Allanson J; Avard D; Giguere Y; Chakraborty P; Carroll JC
Pediatrics; 2016 Jun; 137(6):. PubMed ID: 27244855
[TBL] [Abstract][Full Text] [Related]
16. Informing New Mothers about Newborn Screening Bloodspot Repositories during Postpartum Hospitalization.
Newcomb P; True B; Wells JN; Walsh J; Pehl S
MCN Am J Matern Child Nurs; 2019; 44(6):332-337. PubMed ID: 31633523
[TBL] [Abstract][Full Text] [Related]
17. Impact of incomplete coverage of neonatal dried blood spot screening on estimating HIV-1 seroprevalence.
Hutchinson EJ; Streetly A; Grant C; Pollitt R; Eldridge P; Nicoll A
Epidemiol Infect; 1996 Aug; 117(1):173-7. PubMed ID: 8760966
[TBL] [Abstract][Full Text] [Related]
18. Mucopolysaccharidosis type I newborn screening: Importance of second tier testing for ethnically diverse populations.
Bosfield K; Regier DS; Viall S; Hicks R; Shur N; Grant CL
Am J Med Genet A; 2021 Jan; 185(1):134-140. PubMed ID: 33098355
[TBL] [Abstract][Full Text] [Related]
19. Prenatal Education of Parents About Newborn Screening and Residual Dried Blood Spots: A Randomized Clinical Trial.
Botkin JR; Rothwell E; Anderson RA; Rose NC; Dolan SM; Kuppermann M; Stark LA; Goldenberg A; Wong B
JAMA Pediatr; 2016 Jun; 170(6):543-9. PubMed ID: 27043416
[TBL] [Abstract][Full Text] [Related]
20. African-American:White Disparity in Infant Mortality due to Congenital Heart Disease.
Collins JW; Soskolne G; Rankin KM; Ibrahim A; Matoba N
J Pediatr; 2017 Feb; 181():131-136. PubMed ID: 27836287
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
